Questions, page-19

I only bought Neu briefly . Low $1s from memory .
I wasn’t convinced , all factors totally considered there , and sold , and bought RAC anyway .
I keep researching & checking , constantly.
With all of my holdings, but especially my 2 biomedical companies .
I also sold down besides including unfortunately a parcel of RAC for a margin of safety due to covid wider world markets concerns - in early February . Unfortunately wrt to RAC . RAC fundamentally went Up more than and really only experienced the drop that did due to global huge selloffs but also some manipulation I believe at the time in the market selldown- when a medical Fund took their position . It was an opportunity for new shareholders to buy in - shares are now even more tightly held .

I believe in this management team & the total ethos and aims with Bisantrene and cancer treatment need generally.

I also believe- as with infrastructure developments , health research and the development of better treatments will be a focus of government funding and medical jobs , in highly targeted areas. New oncology drugs developement is desperately needed.
Oncology, most specifically in pharmaceuticals , will be supported by funding and investment particularly , now and in nearterm years .

Much of what is given medically is really quite archaic and not in best interests of the patients.